1. Home
  2. IKT vs GAIA Comparison

IKT vs GAIA Comparison

Compare IKT & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • GAIA
  • Stock Information
  • Founded
  • IKT 2008
  • GAIA 1988
  • Country
  • IKT United States
  • GAIA United States
  • Employees
  • IKT N/A
  • GAIA N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • GAIA Movies/Entertainment
  • Sector
  • IKT Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • IKT Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • IKT 159.2M
  • GAIA 143.5M
  • IPO Year
  • IKT 2020
  • GAIA 1999
  • Fundamental
  • Price
  • IKT $3.05
  • GAIA $4.44
  • Analyst Decision
  • IKT Strong Buy
  • GAIA Strong Buy
  • Analyst Count
  • IKT 2
  • GAIA 1
  • Target Price
  • IKT $6.50
  • GAIA $7.00
  • AVG Volume (30 Days)
  • IKT 451.1K
  • GAIA 23.8K
  • Earning Date
  • IKT 11-14-2024
  • GAIA 11-04-2024
  • Dividend Yield
  • IKT N/A
  • GAIA N/A
  • EPS Growth
  • IKT N/A
  • GAIA N/A
  • EPS
  • IKT N/A
  • GAIA N/A
  • Revenue
  • IKT $1.00
  • GAIA $86,644,000.00
  • Revenue This Year
  • IKT N/A
  • GAIA $13.81
  • Revenue Next Year
  • IKT N/A
  • GAIA $14.30
  • P/E Ratio
  • IKT N/A
  • GAIA N/A
  • Revenue Growth
  • IKT N/A
  • GAIA 9.28
  • 52 Week Low
  • IKT $1.12
  • GAIA $2.59
  • 52 Week High
  • IKT $4.20
  • GAIA $6.53
  • Technical
  • Relative Strength Index (RSI)
  • IKT 51.80
  • GAIA 30.39
  • Support Level
  • IKT $2.90
  • GAIA $4.53
  • Resistance Level
  • IKT $4.20
  • GAIA $4.91
  • Average True Range (ATR)
  • IKT 0.41
  • GAIA 0.32
  • MACD
  • IKT -0.07
  • GAIA -0.10
  • Stochastic Oscillator
  • IKT 11.54
  • GAIA 8.14

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an international presence.

Share on Social Networks: